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Abstract
Background: Dosimetry for Ultrasound Therapy (DUTy) is a large international project which addresses the development
of a metrological infrastructure for the determination of ultrasound exposure and dose to tissue.
Methods: In order to seek the views of the wider therapy ultrasound community and to review dose and in situ
exposure quantities that have been suggested or used previously, a web-based questionnaire containing a range of
questions covering the type of ultrasound equipment that is used and the range of applications for which it has been
developed was created at www.surveymonkey.com. This questionnaire was intended to cover any contemporary
therapeutic ultrasound application (including physiotherapy, lithotripsy and drug delivery) and asked specific questions
about quantification of in situ exposure and dose, especially as relevant to treatment planning, standardisation and/or
regulation.
Results: This paper summarises the 123 responses submitted between February and September 2014 to the questions
on clinical applications, equipment, quality assurance (QA) and measurement and standards, as well as to those relating
to an understanding of “dose” in the context of ultrasound. The full set of anonymous responses is available in an
additional Excel file.
Conclusions: The results clearly demonstrate the need not only for further improvements in measuring devices
and for measurement guidelines but also for a wider dissemination and higher awareness of existing standards.
Whilst it is unlikely that a single definition of dose can be sufficient for all ultrasound treatment modalities, the
answers clearly indicate that many aspects would benefit from clear definitions of relevant dose quantities and
shed light on the preferred form of such definitions.
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Background
This work forms part of a project entitled Dosimetry for
Ultrasound Therapy (DUTy) which is supported in part
by the European Metrology Research Programme, jointly
funded by the EMRP participating countries within
EURAMET and the European Union. The project is coor-
dinated by the National Physical Laboratory (UK) in part-
nership with eight other institutes (www.duty-project.eu).
The aim of the project is to address the metrological infra-
structure for the determination of ultrasound exposure
and dose to tissue. One of its tasks required a review of
the in situ exposure and dose quantities that have been
suggested, or previously used, and sought to investigate
the views of the wider therapy ultrasound community.
This paper summarises the 123 responses submitted
to questions about clinical applications, equipment, QA
and measurement and standards, as well as to questions
related to understanding of “dose” in the context of
ultrasound. The full set of anonymous responses is avail-
able in an additional Excel file [see Additional file 1].
Many of the questions relating to applications, equip-
ment and measurement are similar to those in an earlier
survey carried out by two of the current authors [1, 2].
A companion paper [3] covers in detail the questions on
ultrasound dose from the present survey and also dis-
cusses a proposed framework for exposure and dose
quantities: readers with an interest in the dose aspects
are advised to refer to this earlier paper.
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Methods
The set of questions was intended to help give a pic-
ture of the R&D currently going into therapeutic ultra-
sound. It covered equipment and measurements
related to any contemporary therapeutic ultrasound
applications (including, for instance, physiotherapy,
lithotripsy and drug delivery).
The survey was advertised through the International
Society of Therapeutic Ultrasound (ISTU) mailing list,
by the Focused Ultrasound Foundation, by notices at the
ISTU 2014 conference in Las Vegas and by emails to
personal contacts of the DUTy team members. It was
divided into four main sections which are as follows:
 Your therapeutic ultrasound application
(Q1–Q11)—this asked about the applications of
therapeutic ultrasound with which the respondents
had significant involvement and about the transducers
and acoustic fields with which they worked.
 Measurements you currently perform
(Q12–Q24)—this was primarily related to the
transducer input/output characteristics and the
acoustic field generated in water.
 Your measurement needs (Q25–Q26)—this asked
about the respondents’ perception of the
shortcomings of the acoustic field measurements
they currently make and what their priorities for
future improvements were.
 Your opinion about dose (Q27–39)—this enquired
about the application of the concept of “dose” to
therapeutic ultrasound.
However, the breakdown of results presented here is
grouped slightly differently, in terms of respondents,
applications, equipment used, QA and measurement,
standards and dose. Detailed questions about specific ex-
posure and dose quantities are not covered here, but
they are available in the full dataset in the additional
Excel file [see Additional file 1] and are presented in a
separate paper [3] which also discusses a proposed
framework for exposure and dose quantities.
Results
The results for most of the questions are presented in
this section. The complete questions as well as the pos-
sible answers and their response percentages can be
found in the additional Excel file [see Additional file 1].
The additional file also contains a few questions that are
not mentioned in this section.
Respondents
There were 123 responses, with 90 completing the ques-
tionnaire fully, including the final questions on dose. The
respondents covered most disciplines with approximately
30 % in each of biological effects research and systems de-
velopment, and a further 10 % in measurement or QA;
5 % were clinical users, 5 % involved with standards/regu-
lation and 5 % in modelling/treatment planning. The
remaining 15 % were involved in “other” areas (Q42).
There was a wide range in length of experience, with
responses being quite evenly spread between 2 and
20 years (Q41); nearly half of the replies were from the
USA (34 %) and UK (13 %), with the remaining respon-
dents being from a total of 13 other countries including
France, Germany and China (Q40).
Applications
The most common application area (Q1) was thermal
ablation (including high-intensity focused ultrasound
(HIFU)) followed by drug delivery; next were generic
areas not related to a specific treatment (for example,
general field modelling or biological interaction mecha-
nisms) and metrology/QA (Fig. 1a). The major mecha-
nisms (Q2) thought to be involved were cell destruction
by heat and by cavitation (Fig. 1b), but non-lethal cell
modification was also substantial. Within those that did
work on specific treatments, many tissue types were rep-
resented (Fig. 1c). We asked how much time was directed
towards curative treatment of cancer and other categories
of treatment (Q3): on average, 29 % of the effort went
towards curative cancer treatment with 12 % giving pallia-
tive treatment and a further 15 % working with benign
tumours (Fig. 2).
Equipment used
Questions were asked about the range of ultrasound
characteristics for equipment used: output power, fre-
quency, negative pressure, pulsing, transducer diameter,
focal length and F-number. The responses are sum-
marised in Figs. 3 and 4: the typical system had a trans-
ducer with a diameter between 2 and 10 cm (Q9), focused
at 5 to 10 cm (Q10) and operating at frequencies between
0.5 and 2 MHz (Q6). Output power was between 10 and
100 W (Q5) with a peak negative pressure between 0.5
and 5 MPa (Q7) and with either a continuous wave or a
burst length between 5 cycles and 1 ms (Q8). These
results clearly demonstrate the great diversity of the ultra-
sound sources employed for therapeutic purposes and,
therefore, the complexity of appropriate characterisation
for this range of sources.
QA and measurement
The equipment used for measurement under different
circumstances, the parameters measured, the phantoms
and biological models used and the approach taken
were also of interest: these questions and responses are
shown in Fig. 5. For acoustic measurements such as
pressure, intensity or power, 46 % of respondents said
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they made measurements at, or close to, typical settings
for use and 28 % made measurements at lower settings
and extrapolated to high levels (Q16). For measure-
ments of heating, cavitation or other effects, an even
higher percentage (69 %) measured at, or close to, typ-
ical settings for use (Q18).
As might be expected, fresh ex vivo animal tissue is
the most common biological model used (Fig. 6)
followed equally by small and large animal models and
cell cultures (Q20). One in six respondents was involved
with human studies. Ex vivo tissue also tops the non-
biological models ahead of agar, polyacrylamide and gel-
atine gels (Q19).
We also asked about how the effectiveness of a therapy
was assessed (Q21): post-treatment imaging (MR, CT or
ultrasound) was the most widely used, closely followed
by histology (Fig. 7).
Standards
Recently, two new IEC Standards (IEC 60601-2-62 [4],
IEC 62555 [5]) and a technical specification (IEC 62556
[6]) have been published, following a strategy laid out in
an earlier technical report (IEC 62649 [2]). In order to
test awareness of these documents, the respondents
were asked about these (Fig. 8a, Q22) and other IEC
publications relevant to some aspects of medical ultra-
sound (Fig. 8b and c, Q23–Q24). The full list of the
standards listed, including their titles, is given in Table 1.
The highest numbers for awareness and regular use were
found for IEC 61161 and 62127-1. This correlates with
the answers to two other questions we asked about rou-
tine tests (Q13) and measurement equipment (Q15),
where hydrophone measurements (63 %) and output
power measurements (48 %) were found to be the most
common measurements, and the most common meas-
urement devices were needle hydrophones (69 %) and
radiation force balances (51 %).
Questions were also asked about the perceived short-
comings of the measurement methods being used (Fig. 9)
as this should indicate where improvements are likely to
be of most benefit in future standards and guidelines
(Q25). It is noteworthy that less than 50 % of the re-
spondents felt that they could characterise their equip-
ment satisfactorily. The answers clearly indicate that the
development of more robust sensors and/or sensors for
use in clinical systems, and of guidelines for measure-
ments in situ (i.e. not in water), or for nonlinear derat-
ing, should be of highest priority.
a
b
c
Fig. 1 Responses to questions Q1 (a), Q4 (b) and Q2 (c) related to
clinical applications. Multiple answers were possible (“Please tick all
that apply”)
Fig. 2 Responses to question Q3. Each respondent’s total does not
have to add up to 100 %
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Another question asked (Q12) was “Is there a particu-
lar exposure geometry in your application that makes
acoustic field measurement difficult?” Forty-six percent
said that the geometry for their work was straightfor-
ward, but the other answers indicated that future work
should be directed towards measurements in acoustic
fields with multiple foci or complex focal distributions
(22 %), multiple independent beams (15 %) and specially
formed transducers (14 %) (such as intraluminal or
intravascular devices): the need to measure close to the
transducer surface or “inside the bowl” was also noted.
What is “dose”?
Within this section of the questionnaire, the participants
were asked about their own usage of the term “dose” with
respect to therapeutic ultrasound (Q28) as well as whether
they thought that it has a generally understood meaning
(Q27). Although responses about the general understand-
ing were widely spread with “There are several different
views none of which predominates” being the most com-
mon answer (33 %, Fig. 10a), the question about the
respondents’ own understanding of the term yielded a
clear “winner”, as more than one third (36 %) chose “It
means something quantifiable about the amount of energy
a
b
c
Fig. 4 Responses to questions Q9 to Q11 (a–c) related to equipment
characteristics. Multiple answers were possible (“Please tick all that apply”)
a
b
c
d
Fig. 3 Responses to questions Q5 to Q8 (a–d) related to equipment
characteristics. Multiple answers were possible (“Please tick all that apply”)
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absorbed by the target tissue” as the answer that most
closely described their opinion (Fig. 10b).
In agreement with that, the two potential definitions
based on energy (“Absorbed energy per unit mass” (Q36)
and “Applied total acoustic energy” (Q37)) were always
among the top three, when rated against relevance to the
respondents’ own application, relevance to other applica-
tions and acceptability (Q34–Q39, see Additional file 1 or
[3] for further details). When “Familiarity” was assessed,
“Absorbed energy per unit mass” yielded the highest per-
centage on “Seen in other literature”, indicating that this
term is much more common in radiotherapy and the quan-
tification of electromagnetic waves. This preference for “en-
ergy” was also reflected by the answers to Q33, where
“Acoustic power” and “Exposure time” (whose product is
energy) were both believed to be important for the effect-
iveness of their application by 79 % of the respondents.
a
b
c
Fig. 5 Responses to questions Q13 to Q15 (a–c) related to
measurements made. Multiple answers were possible (“Please tick
all that apply”)
a
b
c
Fig. 6 Responses to questions Q17 (a), Q19 (b) and Q20 (c) related
to the measurements made. Multiple answers were possible (“Please
tick all that apply”)
Fig. 7 Responses to questions Q21 related to the determination of
the therapeutic effectiveness. Multiple answers were possible
(“Please tick all that apply”)
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For all of the four criteria mentioned above, “Thermally
equivalent time” was the most popular option—52 %
claimed to “Use it regularly” under the “Familiarity” sec-
tion, 40 % found it “Very relevant” when asked about its
“Relevance to my own application”, 52 % thought that it
was “Generally acceptable” and 30 % assumed that it was
“Relevant to most” when asked to comment on “Relevance
to other applications”. For the last category, “Applied total
acoustic energy” had a slightly higher score (34 %).
The strong relationship between the understanding of
the term “dose” and thermal mechanisms is also shown
by the answers to Q29 (86 % thought dose (as they
understood it) is relevant to effects mediated by thermal
mechanisms) and Q32, where 70 % thought that “ther-
mal mechanisms” should be of highest priority for the
development of future standards.
The participants were given a further list of eight
aspects of ultrasound therapy with the request to score
whether these would benefit “substantially” or “a little”,
or are “likely to become worse” from a common under-
standing of “dose” (Fig. 11a). Most aspects received the
highest responses for “Likely to benefit substantially”
(with 64 % for “Better planning of treatment parameters
in advance” being the highest). The exceptions were
“Greater acceptability for new treatments” (where 45 %
selected “Likely to benefit a little”) and “Better education
of patient before treatment” (where 38 % selected “Not
likely to make any difference”).
As a step on the route towards a common definition
of “dose”, the participants were given pairs of character-
istics for which they were asked to favour one (Fig. 11b).
Discussion
The majority of the questions in the first three sections
were straightforward to understand and to answer. The
answers on the topic of acoustic conditions used on the
one hand not only show the challenging great diversity of
conditions (from P < 0.1 W to P > 1000 W, from f <
0.1 MHz to f > 5 MHz, from pr < 0.1 MPa to pr > 20 MPa,
from less than five wave cycles to continuous wave) but
also clearly indicated the most common regimes for most
of the quantities, on which further development of stan-
dards, definitions and measuring devices should focus.
However, the section about dose was more problematic
because, although the word “dose” is widely used in differ-
ent areas of medicine, it is not always used in exactly the
same way. This makes it difficult to decide what is most
appropriate for ultrasound therapy and to compare re-
sponses on an equal basis. It was necessary, therefore, to
provide some guidance to respondents whilst trying not to
bias the answers in any way. The respondents were given
descriptions of the usage of “dose” based on wording from
Wikipedia entries:
 In biochemistry, dose is the quantity of something
(chemical, physical, or biological) that may impact
an organism biologically; the greater the quantity,
the larger the dose.
 In medicine, the term is usually applied to the
quantity of a drug or other agent administered for
therapeutic purposes.
 In toxicology, dose may refer to the amount of a
harmful agent (such as a poison, carcinogen, mutagen,
or teratogen), to which an organism is exposed.
 For ionising radiation absorbed dose is a measure of
the energy deposited in a medium by ionizing
radiation per unit mass of the medium.
It is not necessary for there to be a single-dose quan-
tity which is suitable for all therapeutic ultrasound
a
b
c
Fig. 8 Responses to questions Q22 to Q24 (a–c) about the awareness
of IEC standards related to ultrasound
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applications. For instance, dose for lithotripsy may be
very different to dose for physiotherapy. The participants
were asked specifically about several quantities which
are sometimes used in ultrasound but which are dimen-
sionally very different:
 Total acoustic energy output (SI unit: joule)
 Absorbed energy per unit mass (SI unit: joule/kg)
 Intensity-time-integral (SI unit: joule/m2)
 Local cavitation index (SI unit: dimensionless or
MPa/√MHz)
 Thermally equivalent time (commonly called “thermal
dose” or “cumulative equivalent minutes at 43 °C”)
(SI unit: s)
The responses to these questions are covered in detail
in a separate paper [3], but some basic results will be
briefly discussed here as well. The two quantities which
are most used by the participants were thermally equiva-
lent time and total applied energy, and these were also
the quantities that were seen as being of most direct
relevance to the individual’s own work and also of most
Table 1 Full list of the standards given in the questionnaire
Number Type Name Ed. Year Topic
60601-2-62 [4] S Medical electrical equipment - Part 2-62: Particular requirements for the basic safety and essential
performance of high intensity therapeutic ultrasound (HITU) equipment
1.0 2013 HITU
62555 [5] S Ultrasonics - Power measurement - Output power measurement for high intensity therapeutic
ultrasound (HITU) transducers and systems
1.0 2013 HITU
62556 [6] TS Ultrasonics - Field characterization - Specification and measurement of field parameters for high
intensity therapeutic ultrasound (HITU) transducers and systems
1.0 2014 HITU
62649 [2] TR Requirements for measurement standards for high intensity therapeutic ultrasound (HITU) devices 1.0 2010 HITU
60601-2-5 [7] S Medical electrical equipment - Part 2-5: Particular requirements for the basic safety and essential
performance of ultrasonic physiotherapy equipment
3.0 2009 PT
61689 [8] S Ultrasonics - Physiotherapy systems - Field specifications and methods of measurement in the
frequency range 0,5 MHz to 5 MHz
3.0 2013 PT
62462 [9] TS Ultrasonics - Output Test - Guide for the maintenance of ultrasound physiotherapy systems 1.0 2007 PT
61846 [10] S Ultrasonics - Pressure pulse lithotripters - Characteristics of fields 1.0 1998 LT
60601-2-36 [11] S Medical electrical equipment - Part 2-36. Particular requirements for the safety of equipment for
extracorporeally induced lithotripsy
2.0 2014 LT
61161 [12] S Ultrasonics - Power measurement - Radiation force balances and performance requirements 3.0 2013 Gen
62127-1 [13] S Ultrasonics - Hydrophones - Part 1: Measurement and characterization of medical ultrasonic fields
up to 40 MHz
1.1 2013 Gen
62127-2 [14] S Ultrasonics - Hydrophones - Part 2: Calibration for ultrasonic fields up to 40 MHz 1.1 2013 Gen
62127-3 [15] S Ultrasonics - Hydrophones - Part 3: Properties of hydrophones for ultrasonic fields up to 40 MHz 1.1 2013 Gen
61847 [16] S Ultrasonics - Surgical systems - Measurement and declaration of the basic output characteristics 1.0 1998 Gen
62799 [17] TR Models for evaluation of thermal hazard in medical diagnostic ultrasonic fields 1.0 2013 Gen
62359 [18] S Ultrasonics - Field characterization - Test methods for the determination of thermal and mechanical
indices related to medical diagnostic ultrasound fields
2.0 2010 Gen
61949 [19] S Ultrasonics - Field characterization - In situ exposure estimation in finite-amplitude ultrasonic beams 1.0 2007 Gen
61828 [20] S Ultrasonics - Focusing transducers - Definitions and measurement methods for the transmitted fields 1.0 2001 Gen
61205 [21] S Ultrasonics - Dental descaler systems - Measurement and declaration of the output characteristics 1.0 1993 Other
S full Standard, TS technical specification, TR technical report, HITU high-intensity therapeutic ultrasound, PT physiotherapy, LT lithotripsy, Gen general medical ultrasound
Fig. 9 Responses to question Q25 about perceived shortcomings of
current measurement methods
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general relevance. They were also, therefore, the quan-
tities likely to be most acceptable to the wider commu-
nity. Absorbed energy per unit mass was generally the
next highest scoring, but it should be noted that this
quantity (coupled to the thermal properties of the tissue,
local blood flow and other aspects) is what governs the
temperature rise and therefore the thermally equivalent
time. So, although not directly important in itself, know-
ledge of these distributions is a critical step in planning
a treatment.
Summary and conclusions
This paper summarises the 123 responses submitted to on-
line survey questions about therapeutic ultrasound, which
was prepared as part of the EMRP project “Dosimetry for
Ultrasound Therapy” and hosted at www.surveymonkey
com. There were questions on clinical applications, equip-
ment, QA and measurement and standards, as well as
some questions related to understanding of the term
“dose” in the context of ultrasound. The full set of anon-
ymised responses is available as an additional Excel file and
a separate paper [3] has been published which discusses
exposure and dose in more detail and presents a
framework for underpinning future standards and im-
proved metrology in this area.
A clear result from this survey is that less than 50 % of
the respondents felt that they could characterise their
equipment satisfactorily, clearly demonstrating the need
for further improvements in measuring devices and for
measurement guidelines.
Another finding is that, among the respondents, only
50 % are aware of the relevant standards dealing with
therapeutic ultrasound devices or ultrasound in general.
On the other hand, an encouraging 45 % of the respon-
dents expressed their willingness to participate in future
development of standards (Q43).
a
b
Fig. 10 Responses to questions Q27 (a) and Q28 (b) about general
and personal usage of the word “dose”
a
b
Fig. 11 Responses to questions Q30 (a) and Q31 (b) about possible
benefits of a better understanding of “dose” and possible characteristics
of “dose”
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Another result worth emphasising is that the answers
clearly indicate that the respondents assume that many as-
pects would benefit from clear definitions of dose quan-
tities for therapeutic ultrasound (Q30). Concerning the
particular “form” or characteristics of such a definition, it is
a noteworthy result that for all pairs in Q31, a clear “win-
ner” was obtained. On balance, there was a preference for
dose to be a spatially and temporally variable quantity
which is related to absorption of energy in the exposed
medium. Its role should be more directed towards improv-
ing treatment than in addressing safety concerns. Only the
pair “Related to measurable physical quantity” vs. “Related
to tissue effects” was unclear, perhaps reflecting the lack of
traceable quantities that are biologically based.
Availability of supporting data
The data set supporting the results of this article is in-
cluded within the article’s additional file:
 File name: “Shaw et al. 2015—Additional File 1.xlsx”
 File format: Microsoft Office Excel,.xlsx
 Title of data: Full set of anonymous responses to the
survey
 Description of data: The file contains an overview
sheet and 44 sheets for the 44 questions of the survey
Additional file
Additional file 1: Full set of anonymous responses to the survey. The
file contains an overview sheet and 44 sheets for the 44 questions of the
survey. (XLSX 154 kb)
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